Talacotuzumab
Talacotuzumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Talacotuzumab is under investigation in clinical trial NCT01632852 (A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission).
| Trade Name | Talacotuzumab |
| Generic | Talacotuzumab |
| Talacotuzumab Other Names | Talacotuzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Talacotuzumab
